Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorDana-Farber Cancer Institute

About this trial

To assess the feasibility of an expedited referral process for the obese endometrial cancer or EIN patient from her gynecologic oncologist to the Brigham Center for Metabolic and Bariatric Surgery (CMBS) in order to undergo concurrent weight loss surgery and hysterectomy within 8 weeks of first appointment with a gynecologic oncologist (or 12 weeks for EIN patients).

Eligibility criteria

Qualifiers

Female adults at least 18 years of age

A BMI of 35-39.99 and 1 or more severe obesity-related co-morbidities

Tissue diagnosis (usually endometrial biopsy) of grade 1 endometrial carcinoma or EIN.

Disqualifiers

Younger than 18 years old

BMI < 35

Without a tissue diagnosis, or with a grade 2 or greater endometrial cancer tissue diagnosis

Pregnant participants will be excluded from this study.

Trial design

Treatments tested in this trial

  • CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor

Brigham and Women's Hospital

Sponsor institution